Major drugmakers are participating in a new FDA fast-track review program despite concerns about potential legal risks. The ...
The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
A kidney transplant fast track program improved waitlisting and kidney transplantation rates compared with standard care, and especially reduced disparities for Black patients. A kidney transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback